Vitamin D supplements help to fill the gaps, but that can come at a cost if they’re taken with certain medications. “Like any ...

There are a couple categories of conditions that can manifest with random bruising—though they typically surface with other ...

This in-depth feature explores the challenges and controversies surrounding the diagnosis and management of PANDAS.

If you have brittle nails, swollen hands or unusually pale fingertips it may be more than just a damper to your manicure. It ...

European Medicines Agency recognizes potential of lead compound MP1032 in addressing a high unmet medical need in Duchenne Muscular Dystrophy (DMD)Designation is paving the way for safer long-term ...

The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina represents a ...

LONDON, UK I July 28, 2025 I GSK plc (LSE/NYSE: GSK) today announced it has entered into agreements with Hengrui Pharma (600276.SH; 01276.HK) to develop up to ...

The pharmaceutical market is being altered with the evolution and use of urate-lowering drugs, NSAIDs, corticosteroids, and ...

Heavy monsoon rains in Mumbai have led to a sharp rise in neurocysticercosis cases caused by tapeworm infection.

GSK has moved to shore up its R&D pipeline with a strategic-level deal with China's Jiangsu Hengrui Pharma that spans a dozen drug candidates and could be worth up to $12.5 billion.

Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major ...

Includes license for potential best-in-class PDE3/4 inhibitor (HRS-9821) in clinical development for treatment of COPD <li /> Additional ...